CURE’s gynecologic cancer page is an extensive resource of cancer information featuring the latest gynecologic cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on gynecologic cancer.
May 9th 2024
Adding Keytruda to chemotherapy with or without radiotherapy did not improve disease-free survival in newly diagnosed high-risk endometrial cancer.
FDA Grants Accelerated Approval to Jemperli for Endometrial Cancer
April 22nd 2021Jemperli (dostarlimab) received accelerated approval from the Food and Drug Administration for the treatment of patients with recurrent or advanced endometrial cancer whose disease has progressed on, or following, prior treatment with a platinum-containing chemotherapy and whose cancers have a specific genetic biomarker known as deficient mismatch repair.